Article
Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS.
Annals of neurology - 1 Oct 2004
Zheng Chengyun, Nennesmo Inger, Fadeel Bengt, Henter Jan-Inge
Abstract excerpt
Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease associated with the death of motor neurons in the spinal cord and brainstem. The cause of ALS is unknown and there is no cure. This study demonstrates, for the first time, that vascular endothelial growth factor (VEGF) delays progression of symptoms and prolongs survival in a Cu/Zn superoxide dismutase (SOD1) transgenic mouse model of ALS....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
